Hoth Therapeutics Inc (HOTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 8,215 | 7,953 | 11,066 | 14,101 | 7,302 |
| Operating Income | -8,215 | -7,953 | -11,066 | -14,101 | -7,302 |
| Other Income | 27 | -153 | -306 | -212 | 104 |
| Pre-tax Income | -8,188 | -8,106 | -11,372 | -14,314 | -7,198 |
| Net Income Continuous | -8,188 | -8,106 | -11,372 | -14,314 | -7,198 |
| Net Income | $-8,188 | $-8,106 | $-11,372 | $-14,314 | $-7,198 |
| EPS Basic Total Ops | -1.28 | -2.38 | -9.50 | -16.02 | -14.50 |
| EPS Basic Continuous Ops | -1.28 | -2.38 | -9.49 | -16.03 | -14.56 |
| EPS Diluted Total Ops | -1.28 | -2.38 | -9.50 | -16.02 | -14.50 |
| EPS Diluted Continuous Ops | -1.28 | -2.38 | -9.49 | -16.03 | -14.56 |
| EPS Diluted Before Non-Recurring Items | -1.28 | -2.30 | -9.50 | -16.00 | -14.50 |
| EBITDA(a) | $-8,215 | $-7,953 | $-11,066 | $-14,101 | $-7,301 |